No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
JAKK Jakks Pacific
- 19.730
- -3.730-15.90%
Close Apr 25 16:00 ET
213.05MMarket Cap7.07P/E (TTM)
20.196High18.420Low419.30KVolume19.150Open23.460Pre Close8.15MTurnover5.29%Turnover Ratio5.67P/E (Static)10.80MShares36.84052wk High1.13P/B156.28MFloat Cap15.30052wk Low--Dividend TTM7.92MShs Float298.567Historical High--Div YieldTTM7.57%Amplitude3.000Historical Low19.439Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Jakks Pacific Inc (JAKK) Q1 2024 Earnings: A Detailed Financial Overview
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling by around 100 points on Thursday.The Dow traded down 1.20% to 37,998.27 while the NASDAQ fell 0.85% to 15,578.58.
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
Express News | JAKKS Pacific Shares Are Trading Lower After the Company Reported Worse-thane-expected Q1 Adjusted EPS Results
NDLS and EJH Among Consumer Discretionary Movers
Q1 2024 JAKKS Pacific Inc Earnings Call
Comments
Despite JAKKS Pacific's low P/E ratio and predicted future earnings growth, investors remain skeptical due to the company's recent earnings instability and potential risks.
Investors Give JAKKS Pacific, Inc. (NASDAQ:JAKK) Shares A 26% HidingDespite recent share price pullback, the business is doing well enough to support the current price. The transition from loss to profitability justifies a strong share price gain. The share price momentum remains strong, suggesting a closer look at the stock might be worth it.
With shrinking earnings, JAKKS Pacific's low P/E ratio is justified. The potential for earnings improvement isn't seen as enough for a higher P/E ratio, leading to skepticism about significant share price growth.
ColumnsToday's pre-market stock movers: BP, CHGG, PFE, EL and more
Gainers:
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
17
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg